Literature DB >> 18429699

Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition.

Katrina L Bogan1, Charles Brenner.   

Abstract

Although baseline requirements for nicotinamide adenine dinucleotide (NAD+) synthesis can be met either with dietary tryptophan or with less than 20 mg of daily niacin, which consists of nicotinic acid and/or nicotinamide, there is growing evidence that substantially greater rates of NAD+ synthesis may be beneficial to protect against neurological degeneration, Candida glabrata infection, and possibly to enhance reverse cholesterol transport. The distinct and tissue-specific biosynthetic and/or ligand activities of tryptophan, nicotinic acid, nicotinamide, and the newly identified NAD+ precursor, nicotinamide riboside, reviewed herein, are responsible for vitamin-specific effects and side effects. Because current data suggest that nicotinamide riboside may be the only vitamin precursor that supports neuronal NAD+ synthesis, we present prospects for human nicotinamide riboside supplementation and propose areas for future research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18429699     DOI: 10.1146/annurev.nutr.28.061807.155443

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  239 in total

1.  Insights into colon cancer etiology via a regularized approach to gene set analysis of GWAS data.

Authors:  Lin S Chen; Carolyn M Hutter; John D Potter; Yan Liu; Ross L Prentice; Ulrike Peters; Li Hsu
Journal:  Am J Hum Genet       Date:  2010-06-11       Impact factor: 11.025

2.  Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool.

Authors:  Maria Pittelli; Laura Formentini; Giuseppe Faraco; Andrea Lapucci; Elena Rapizzi; Francesca Cialdai; Giovanni Romano; Gloriano Moneti; Flavio Moroni; Alberto Chiarugi
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

Review 3.  Protein acetylation in metabolism - metabolites and cofactors.

Authors:  Keir J Menzies; Hongbo Zhang; Elena Katsyuba; Johan Auwerx
Journal:  Nat Rev Endocrinol       Date:  2015-10-27       Impact factor: 43.330

4.  Stable isotopes and LC-MS for monitoring metabolic disturbances in Friedreich's ataxia platelets.

Authors:  Andrew J Worth; Sankha S Basu; Eric C Deutsch; Wei-Ting Hwang; Nathaniel W Snyder; David R Lynch; Ian A Blair
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

5.  Accurate measurement of nicotinamide adenine dinucleotide (NAD⁺) with high-performance liquid chromatography.

Authors:  Jun Yoshino; Shin-Ichiro Imai
Journal:  Methods Mol Biol       Date:  2013

Review 6.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

7.  Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy.

Authors:  Nicolas Diguet; Samuel A J Trammell; Cynthia Tannous; Robin Deloux; Jérôme Piquereau; Nathalie Mougenot; Anne Gouge; Mélanie Gressette; Boris Manoury; Jocelyne Blanc; Marie Breton; Jean-François Decaux; Gareth G Lavery; István Baczkó; Joffrey Zoll; Anne Garnier; Zhenlin Li; Charles Brenner; Mathias Mericskay
Journal:  Circulation       Date:  2017-12-07       Impact factor: 29.690

Review 8.  Regulation of NAD+ metabolism, signaling and compartmentalization in the yeast Saccharomyces cerevisiae.

Authors:  Michiko Kato; Su-Ju Lin
Journal:  DNA Repair (Amst)       Date:  2014-08-02

Review 9.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

Review 10.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.